chengdu kanghong pharmaceuticals group co ltd
Sagent Pharma To Acquire Remaining Interest In Chengdu Kanghong Pharma
U.S. biotech Sagent Pharma will acquire the remaining 50 percent interest of the Kanghong Sagent (Chengdu) Pharmaceutical Corporation Limited joint venture.